Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
Past Issue

Vol. 5, No. 6
Nov–Dec  1999
 

 

 
Research

Supplementing Tuberculosis Surveillance with Automated Data from Health Maintenance Organizations

Deborah S. Yokoe,* Girish S. Subramanyan,* Edward Nardell,† Sharon Sharnprapai,† Eugene McCray,‡ and Richard Platt*§
*Brigham and Women's Hospital, Boston, Massachusetts, USA; †Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; and §Harvard Medical School, Harvard Pilgrim Health Care,

Boston, Massachusetts, USA


This table was inadvertently left off Yokoe's original article and added on the date at the bottom of this page. We apologize for any inconvenience this may have caused.
  

Table 3. Reasons for meeting screening criteria among individuals without incident tuberculosis (TB) who had automated ambulatory-patient records


Screening criteria that include a TB diagnosis code or multiple anti-TB drugs

       

Diagnosis codeb

 
       

for TB,

 
       

a microbiology

At least one

Reasons why

Two or more

Diagnosis

Diagnosis

code, c and a

anti-TB druga and

non-TB cases met

anti-TB

codeb for

codeb for

a radiology

an ICD-9 diagnosis

screening criteria

drugsa

active TB

pulmonary TB

coded

code for TB


Active TB diagnosed outside study window

9 (13%)

0

0

0

0

Suspected active TB

26 (37%)

2 (67%)

4 (5%)

19 (58%)

6 (86%)

TB prophylaxis

11 (15%)

0

0

0

0

Prenatal TB screening

0

0

57 (76%)

0

0

Prior history of TB

0

0

5 (7%)

7 (21%)

0

Other mycobacterial infections

23 (32%)

0

0

0

0

Treatment of other conditions

2 (3%)

0

0

0

0

No documentation of reason in HMO medical record

0

1 (33%)

9 (12%)

7 (21%)

1 (14%)

Total no. without

71

3

75

33

7

incident active TB

         

aPharmacy dispensing data; antituberculosis drugs include isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin, capreomycin, kanamycin, ethionamide, para-aminosalicyclic acid, and cycloserine.
b
Ambulatory codes were obtained from automated ambulatory records in the staff model division and from claims in the network and group model division.
c
Microbiology codes include COSTAR (coding system for automated ambulatory-patient records [10]) or ICD-9CM (International Classification of Diseases, 9th Revision Clinical Modification) procedure codes for acid fast bacilli smear, culture and sensitivities and microscopy examination of sputum.
d
Radiology codes include current procedures terminology (CPT), COSTAR, or ICD-9 procedure codes for chest radiograph, thoracic computer- assisted tomography (CT), or thoracic magnetic resonance imaging (MRI).

Back to article

 


Comments to the EID Editors
Please use this form to submit comments to the EID Editors.

Email (optional)


Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed June 14, 2001

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention